Strategic Partnerships Highlight potential collaboration with TScan Therapeutics on automated manufacturing for TCR-T therapies, leveraging their recent interest in Cellares partnership to streamline clinical production and scale.

Clinical Focus Target opportunities around acute myeloid leukemia and other cancer indications where TCR-T therapies can address unmet needs, aligning with their ongoing clinical development and upcoming conference abstracts.

Operational Growth Offer scalable, compliant manufacturing, logistics, and analytics solutions to support expanding clinical programs as they grow their headcount and move toward broader trials.

Financial Signals Position value propositions around cost-efficient, rapid manufacturing and data-driven processes to help improve burn rate and accelerate timelines, given their mid-market revenue band and public company status.

Industry Engagement Leverage opportunities tied to industry events and partnerships (ASGCT, Needham Conference, ACR Convergence) to propose targeted pilots, joint presentations, and visibility-focused collaborations with potential reuse of their research platform.